Know Labs, Inc. Share Price

Equities

KNW

US4992381032

Advanced Medical Equipment & Technology

Market Closed - Nyse 21:10:00 26/04/2024 BST 5-day change 1st Jan Change
0.6475 USD +5.28% Intraday chart for Know Labs, Inc. +14.97% +27.21%
Sales 2024 * - Sales 2025 * - Capitalization 53.43M 4.28B
Net income 2024 * -15M -1.2B Net income 2025 * -19M -1.52B EV / Sales 2024 * -
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
-3.41 x
P/E ratio 2025 *
-2.7 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 73.57%
More Fundamentals * Assessed data
Dynamic Chart
1 day+5.28%
1 week+14.97%
Current month+2.78%
1 month+1.49%
3 months+63.51%
6 months+149.52%
Current year+27.21%
More quotes
1 week
0.52
Extreme 0.5204
0.65
1 month
0.51
Extreme 0.5069
0.70
Current year
0.37
Extreme 0.371
0.92
1 year
0.23
Extreme 0.23
1.48
3 years
0.23
Extreme 0.23
4.24
5 years
0.23
Extreme 0.23
4.83
10 years
0.11
Extreme 0.1089
18.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 80 07/10/98
Director of Finance/CFO 69 23/05/22
Chief Tech/Sci/R&D Officer 74 11/09/18
Members of the board TitleAgeSince
Chief Executive Officer 80 07/10/98
Director/Board Member 78 22/04/19
Director/Board Member 82 23/05/18
More insiders
Date Price Change Volume
26/04/24 0.6475 +5.28% 52,393
25/04/24 0.615 -0.58% 13,134
24/04/24 0.6186 +6.09% 92,649
23/04/24 0.5831 -4.41% 61,113
22/04/24 0.61 +8.31% 93,444

Delayed Quote Nyse, April 26, 2024 at 09:10 pm

More quotes
Know Labs, Inc. is a provider of non-invasive blood glucose monitoring solutions. The Company is focused on the development and commercialization of its proprietary sensor technology utilizing radio and microwave spectroscopy. When paired with its machine learning platform, the Company’s Bio-RFID sensor technology platform identifies and measures various material or analyte using electromagnetic energy to detect, record, identify and measure the signature of said materials or analytes. The data obtained with its sensor technology is analyzed with the Company’s trade secret algorithms. The Company is focused on analytes relating to human health, the identification, of which provide diagnostic information and require, by their nature, clearance by the United States Food and Drug Administration. The first among those analytes is the non-invasive monitoring of blood glucose levels. Its device provides the user with real-time information on their blood glucose levels.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.6475 USD
Average target price
1 USD
Spread / Average Target
+54.44%
Consensus